DOD Biotech PCL (BKK:DOD) Enterprise Value: ฿484.5 Mil (As of Jul. 05, 2026) ***


BKK:DOD DOD Biotech PCL BKK:DOD
76 GF Score
Price ฿1.19
GF Value ฿1.67
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is DOD Biotech PCL Enterprise Value?

DOD Biotech PCL BKK:DOD +2.59% 76 Enterprise Value is ฿484.5 Mil as of Jul. 05, 2026. GuruFocus rates BKK:DOD with a GF Score™ of 76/100 and a GF Value™ of ฿1.67 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, DOD Biotech PCL's Enterprise Value is ฿484.5 Mil. DOD Biotech PCL's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was ฿5.6 Mil. Therefore, DOD Biotech PCL's EV-to-EBIT ratio for today is 87.16.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, DOD Biotech PCL's Enterprise Value is ฿484.5 Mil. DOD Biotech PCL's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was ฿49.2 Mil. Therefore, DOD Biotech PCL's EV-to-EBITDA ratio for today is 9.84.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, DOD Biotech PCL's Enterprise Value is ฿484.5 Mil. DOD Biotech PCL's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was ฿557.8 Mil. Therefore, DOD Biotech PCL's EV-to-Revenue ratio for today is 0.87.

EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations. As of today, DOD Biotech PCL's Enterprise Value is ฿484.5 Mil. DOD Biotech PCL's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was ฿-9.3 Mil. Therefore, DOD Biotech PCL's EV-to-OCF ratio for today is -52.13.

EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, DOD Biotech PCL's Enterprise Value is ฿484.5 Mil. DOD Biotech PCL's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ฿-87.9 Mil. Therefore, DOD Biotech PCL's EV-to-FCF ratio for today is -5.51.

*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.


DOD Biotech PCL  (BKK:DOD) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

DOD Biotech PCL's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=484.527/5.559
=87.16

DOD Biotech PCL's current Enterprise Value is ฿484.5 Mil.
DOD Biotech PCL's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿5.6 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

DOD Biotech PCL's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=484.527/49.238
=9.84

DOD Biotech PCL's current Enterprise Value is ฿484.5 Mil.
DOD Biotech PCL's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿49.2 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

DOD Biotech PCL's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=484.527/557.824
=0.87

DOD Biotech PCL's current Enterprise Value is ฿484.5 Mil.
DOD Biotech PCL's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿557.8 Mil.

4. EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations.

DOD Biotech PCL's EV-to-OCF for today is:

EV-to-OCF=Enterprise Value (Today)/Cash Flow from Operations (TTM)
=484.527/-9.295
=-52.13

DOD Biotech PCL's current Enterprise Value is ฿484.5 Mil.
DOD Biotech PCL's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿-9.3 Mil.

5. EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow.

DOD Biotech PCL's EV-to-FCF for today is:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=484.527/-87.889
=-5.51

DOD Biotech PCL's current Enterprise Value is ฿484.5 Mil.
DOD Biotech PCL's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿-87.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DOD Biotech PCL Enterprise Value Related Terms


DOD Biotech PCL Enterprise Value Historical Data

* Premium members only.

The historical data trend for DOD Biotech PCL's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DOD Biotech PCL Enterprise Value Chart

DOD Biotech PCL Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,595.37 1,992.89 1,789.36 563.97 505.51

DOD Biotech PCL Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 381.33 517.48 642.99 505.51 732.25

BKK:DOD vs KHC, GIS: Enterprise Value Comparison

For the Packaged Foods subindustry, DOD Biotech PCL's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DOD Biotech PCL Enterprise Value vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, DOD Biotech PCL's Enterprise Value distribution charts can be found below:

* The bar in red indicates where DOD Biotech PCL's Enterprise Value falls into.


BKK:DOD
76GF Score
DOD Biotech PCL BKK:DOD
Enterprise Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DOD Biotech PCL Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

DOD Biotech PCL's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as

DOD Biotech PCL's Enterprise Value for the quarter that ended in Mar. 2026 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Enterprise Value →
What does a Enterprise Value of ฿484.5 Mil mean?
DOD Biotech PCL (BKK:DOD) has a Enterprise Value of ฿484.5 Mil as of Jul. 05, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on DOD Biotech PCL and its competitors.
Is DOD Biotech PCL's Enterprise Value too high?
DOD Biotech PCL's current Enterprise Value is ฿484.5 Mil. Overall, DOD Biotech PCL has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does DOD Biotech PCL's Enterprise Value compare to KHC and GIS?
DOD Biotech PCL's Enterprise Value of ฿484.5 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Consumer Packaged Goods company?
A good Enterprise Value depends on the Consumer Packaged Goods industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on DOD Biotech PCL and its competitors. DOD Biotech PCL's current Enterprise Value is ฿484.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DOD Biotech PCL stock overvalued right now?
Based on GuruFocus' analysis, DOD Biotech PCL (BKK:DOD) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿1.67, compared to a current price of ฿1.19 — trading 28.7% below its estimated fair value. The current Enterprise Value is ฿484.5 Mil. DOD Biotech PCL's overall GF Score™ is 76/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For DOD Biotech PCL (BKK:DOD), the current Enterprise Value is ฿484.5 Mil as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DOD Biotech PCL (BKK:DOD) Overvalued in 2026?

Based on GuruFocus' analysis, DOD Biotech PCL stock appears to be undervalued. The current stock price of ฿1.19 is trading 28.7% below its estimated GF Value™ of ฿1.67. GuruFocus considers DOD Biotech PCL to be Modestly Undervalued.

Key valuation signals for BKK:DOD:

  • Enterprise Value: ฿484.5 Mil
  • GF Value™: ฿1.67 vs. price of ฿1.19 (28.7% below fair value)
  • GF Score™: 76/100 with 5 warning signs

No single metric tells the full story. See the BKK:DOD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


DOD Biotech PCL Business Description

Address No. 111, Moo 2, Tumbol Taa jeen, Amphor Muengsamutsakhon, Samut Sakhon, THA, 74000
DOD Biotech PCL is principally engaged in the manufacture and distribution of food supplements and health drinks of all kinds. The group is principally engaged in the supplement business. Its operations are carried on only in Thailand. Its products include: Capsule; Gel; Jelly; Powder for making drinks; Concentrated water extract (Shot Drink); Softgel; Tablet; Probiotics; Gummies; and Direct-to-Mouth Packaging.
76GF Score

Get the complete analysis for BKK:DOD

Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿1.19
Price
฿1.67
GF Value